Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC
Jung, E., Kim, Y. J., Lee, K., Jang, S., Park, S., Oh, E., Park, M., Kim, S., Ko, D., Kang, Y. K., Nam, K. D., Farrand, L., Nguyen, C. T., La, M. T., Ann, J., Lee, J., Kim, J. Y. & Seo, J. H., 2026 Jan, In: Oncology reports. 55, 1, 13.Research output: Contribution to journal › Article › peer-review
Open Access -
Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer
Jung, E., Kim, J. Y., Ko, D., Seo, J., Lee, S. Y., Lee, D., Kim, S., Park, M., Kim, S., Park, S., Lee, K., Kang, Y. K., Nam, K. D., Kim, Y. J. & Seo, J. H., 2026 Apr, In: International journal of molecular medicine. 57, 4, 80.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum to “Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents” [Eur. J. Med. Chem. (2024) 116620](S0223523424005002)(10.1016/j.ejmech.2024.116620)
La, M. T., Hoang, V. H., Sahu, R., Nguyen, C. T., Nam, G., Park, H. J., Park, M., Kim, Y. J., Kim, J. Y., Ann, J., Seo, J. H. & Lee, J., 2025 Feb 5, In: European Journal of Medicinal Chemistry. 283, 117194.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Phase III of oral paclitaxel (DHP107) vs intravenous paclitaxel in HER2-negative recurrent or metastatic breast cancer (mBC): Primary analysis of a multinational optimal trial (NCT03315364).
Kim, S. B., Xu, B., Sun, T., Zhang, Q., Kostic, S., Wang, X., Tong, Z., Wang, S., Wang, J., Li, W., Lee, K. S., Moon, Y. W., Kang, M. J., Hu, X., Kim, T. Y., Milenkovic, D., Seo, J. H., Kim, J. H., Lee, J. E. & Sohn, J., 2025, In: Journal of Clinical Oncology. 43, 16, p. 1007 1 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer
Ko, D., Park, S., Park, M., Kim, S., Park, J. M., Seo, J., Nam, K. D., Kang, Y. K., Farrand, L., Jung, E., Kim, Y. J., Kim, J. Y. & Seo, J. H., 2025 Dec, In: Experimental Hematology and Oncology. 14, 1, 125.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
New Cervical Cancer Data Have Been Reported by Researchers at Korea University Anam Hospital (Prognostic significance of psoas muscle index at diagnosis in cervical cancer progression)
Lee, W., Lee, K. Y., Kim, J.-H., Seo, J. H., Kim, H., Lee, W.-K., Lee, S. H., Lee, S., Lee, J. K., Min, K. J., Hong, J.-H., Song, J. Y., Min, K., Lee, S., Hong, J.-H., Cho, H.-W., Lee, J.-K. & Song, J.-Y.
26/4/17
1 item of Media coverage
Press/Media: Press / Media
-
New Ovarian Cancer Study Findings Recently Were Reported by Researchers at Korea University Guro Hospital (Enhanced ovarian cancer diagnosis using deep learning on pelvic ultrasound with integrated clinical data: retrospective multicenter study)
Lee, K. Y., Kim, K. H., Kim, J.-H., Seo, J. H., Kim, K. N., Lee, S. H., Lee, J. K., Hong, J.-H., Kim, K., Hong, J.-H., Kim, K., Cho, H.-W. & Lee, J.-K.
26/4/9
1 item of Media coverage
Press/Media: Press / Media
-
Chung Ang University College of Medicine Researchers Illuminate Research in Inflammatory Bowel Disease (Association of early vedolizumab trough levels with clinical, biochemical, endoscopic response and drug optimization during maintenance ...)
26/4/7
1 item of Media coverage
Press/Media: Press / Media
-
CaniCatiCare Launches Precision Cancer Diagnostics for Companion Dogs
26/3/23
1 item of Media coverage
Press/Media: Press / Media
-
154명의 의대 교수 퇴임: 주요 대학 및 명단 공개
Seo, J. H., Lee, Y. H., Jeon, S. W. & Lee, Y.
26/3/20
1 item of Media coverage
Press/Media: Press / Media